Jacobs Levy Equity Management’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
105,632
+63,304
+150% +$600K ﹤0.01% 700
2026
Q1
$362K Buy
42,328
+24,582
+139% +$221K ﹤0.01% 861
2025
Q4
$157K Buy
+17,746
New +$205K ﹤0.01% 895
2025
Q1
Sell
-21,784
Closed -$372K 1221
2024
Q4
$372K Buy
+21,784
New +$378K ﹤0.01% 850

Other funds holding ARDT

Jacobs Levy Equity Management's ARDT Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Ardent Health (ARDT) stake by 150% in Q2 2026, buying an estimated $600K and bringing the position to 105,632 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Jacobs Levy Equity Management first reported a position in ARDT in Q4 2024 and has held it in 4 quarters since. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Jacobs Levy Equity Management held 105,632 shares of Ardent Health worth $1.04M as of Q2 2026.
  • Jacobs Levy Equity Management bought 63,304 Ardent Health shares in Q2 2026, an estimated $600K.
  • Ardent Health made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #700 holding.
  • Jacobs Levy Equity Management first reported a position in Ardent Health in Q4 2024 and has held it in 4 quarters since.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.